MARKER THERAPEUTICS, INC.: cashflow_financing

Value{"amount": 550000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Period2020-01-01 – 2020-03-31
Statuscurrent
EntityMARKER THERAPEUTICS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001104659-20-059515
Retrieved: 2026-08-19T10:54:33.612027+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001094038/cashflow-financing/2020-03-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/175d4f7f-cc73-4ca0-9d6a-89365169d00d

History